Scientists in the southern Ugandan city of Masaka are conducting a phase I trial of a candidate vaccine against the deadly Ebola Bundibugyo virus disease (BDBV), a strain for which no licensed vaccine or effective treatment currently exists.
Scientists in the southern Ugandan city of Masaka are conducting a phase I trial of a candidate vaccine against the deadly Ebola Bundibugyo virus disease (BDBV), a strain for which no licensed vaccine or effective treatment currently exists.
There’s no content to show here yet.
Leave a Reply